drugset / Trial / NCT00767221
Oral Treatment With PL-56 in Patients With IgA Nephropathy - an Explorative Study
NaSingle-groupOpen-labelTreatment
Summary
The study will investigate the effect of PL-56 on albumin leakage and renal function (glomerular filtration rate) in patients with IgA nephropathy. It will also assess the safety of treatment with PL-56.
Timeline
- Start
- 2005-10
- Primary completion
- 2008-11
- Completion
- 2008-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 8 mg | Oral |